212 related articles for article (PubMed ID: 33554686)
1. Chemotherapy and targeted treatments of breast sarcoma by histologic subtype.
Kokkali S; Stravodimou A; Duran-Moreno J; Koufopoulos N; Voutsadakis IA; Digklia A
Expert Rev Anticancer Ther; 2021 Jun; 21(6):591-604. PubMed ID: 33554686
[No Abstract] [Full Text] [Related]
2. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans and gastrointestinal stromal tumor as models for targeted therapy in soft tissue sarcomas.
Koseła-Paterczyk H; Rutkowski P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1107-1116. PubMed ID: 28988501
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Insights of Radiation-Induced Breast Sarcomas: Is There Hope on the Horizon for Effective Treatment of This Aggressive Disease?
Kokkali S; Moreno JD; Klijanienko J; Theocharis S
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456944
[TBL] [Abstract][Full Text] [Related]
5. Current and advancing systemic treatment options for soft tissue sarcomas.
Harris SJ; Benson C; Jones RL
Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
[TBL] [Abstract][Full Text] [Related]
6. Different approaches to advanced soft tissue sarcomas depending on treatment line, goal of therapy and histological subtype.
Martín-Broto J; Reichardt P; Jones RL; Stacchiotti S
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):15-28. PubMed ID: 32349558
[No Abstract] [Full Text] [Related]
7. Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments.
Suarez-Kelly LP; Baldi GG; Gronchi A
Expert Opin Pharmacother; 2019 Aug; 20(12):1503-1515. PubMed ID: 31136210
[No Abstract] [Full Text] [Related]
8. The current reality of soft tissue sarcomas: advances, controversies, areas for improvement, and promising new treatments.
Blay JY; Le Cesne A; Demetri GD
Expert Rev Anticancer Ther; 2020 Apr; 20(sup1):29-39. PubMed ID: 32349562
[No Abstract] [Full Text] [Related]
9. Surgical management of truncal soft tissue sarcoma and other selected soft tissue neoplasms.
Morita SY
Chin Clin Oncol; 2018 Aug; 7(4):38. PubMed ID: 30173529
[TBL] [Abstract][Full Text] [Related]
10. Emerging therapies for adult soft tissue sarcoma.
Radaelli S; Stacchiotti S; Casali PG; Gronchi A
Expert Rev Anticancer Ther; 2014 Jun; 14(6):689-704. PubMed ID: 24555529
[TBL] [Abstract][Full Text] [Related]
11. Treating soft tissue sarcomas with adjuvant chemotherapy.
Patrikidou A; Domont J; Cioffi A; Le Cesne A
Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
[TBL] [Abstract][Full Text] [Related]
12. Histology-driven chemotherapy of soft-tissue sarcoma.
Eriksson M
Ann Oncol; 2010 Oct; 21 Suppl 7():vii270-6. PubMed ID: 20943627
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor.
Baldi GG; Gronchi A; Tazzari M; Stacchiotti S
Expert Rev Anticancer Ther; 2022 May; 22(5):491-503. PubMed ID: 35412415
[TBL] [Abstract][Full Text] [Related]
14. Current state-of-the-art systemic therapy for pediatric soft tissue sarcomas.
Ray A; Huh WW
Curr Oncol Rep; 2012 Aug; 14(4):311-9. PubMed ID: 22535507
[TBL] [Abstract][Full Text] [Related]
15. What's the latest with investigational drugs for soft tissue sarcoma?
Cojocaru E; Napolitano A; Fisher C; Huang P; Jones RL; Thway K
Expert Opin Investig Drugs; 2022 Nov; 31(11):1239-1253. PubMed ID: 36424693
[TBL] [Abstract][Full Text] [Related]
16. Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities.
Esperança-Martins M; Melo-Alvim C; Dâmaso S; Lopes-Brás R; Peniche T; Nogueira-Costa G; Abreu C; Luna Pais H; de Sousa RT; Torres S; Gallego-Paez LM; Martins M; Ribeiro L; Costa L
Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568749
[TBL] [Abstract][Full Text] [Related]
17. Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations.
Li GZ; Raut CP; Hunt KK; Feng M; Chugh R
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():390-404. PubMed ID: 34010054
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of distant metastases versus locally advanced disease in soft tissue sarcomas: An EORTC-STBSG database study.
Verschoor AJ; Litière S; Marréaud S; Judson I; Toulmonde M; Wardelmann E; van der Graaf WT; Le Cesne A; Gronchi A; Gelderblom H
Eur J Cancer; 2018 May; 94():187-198. PubMed ID: 29574364
[TBL] [Abstract][Full Text] [Related]
19. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.
Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL
Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396
[TBL] [Abstract][Full Text] [Related]
20. Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.
Skafida E; Kokkali S; Nikolaou M; Digklia A
Expert Rev Anticancer Ther; 2017 Jun; 17(6):537-543. PubMed ID: 28425820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]